US Stock MarketDetailed Quotes

MTNB Matinas BioPharma

Watchlist
  • 0.6205
  • -0.0235-3.65%
Trading Apr 30 13:04 ET
3.16MMarket Cap-0.12P/E (TTM)

About Matinas BioPharma Company

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.

Company Profile

SymbolMTNB
Company NameMatinas BioPharma
Listing DateMar 2, 2017
Founded2013
CEOMr. Jerome D. Jabbour, J.D.
MarketAMEX
Employees3
Fiscal Year Ends12-31
Address1545 Route 206 South,Suite 302
CityBedminster
ProvinceNew Jersey
CountryUnited States of America
Zip Code07921-9999
Phone1-908-484-8805

Company Executives

  • Name
  • Position
  • Salary
  • Jerome D. Jabbour, J.D.
  • Chief Executive Officer, President and Chairman of the Board
  • 598.00K
  • Keith A. Kucinski, C.P.A.,M.B.A.
  • Chief Financial Officer and Principal Accounting Officer
  • 584.16K
  • Evelyn D’An
  • Independent Director
  • --
  • Dr. Robin L. Smith, M.B.A.,M.D.
  • Independent Director
  • --
  • Keith Murphy
  • Independent Director
  • --
  • Edward Neugeboren
  • Independent Director
  • --

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More